Infusion-Related Reactions with Anti-CD20 Monoclonal Antibody Treatments in Multiple Sclerosis: Traditional Review

GÖNCÜOĞLU, Cansu; ÖKSÜZOĞLU, Kübra Nur; EKİNCİOĞLU, Aygin BAYRAKTAR

doi:10.5336/pharmsci.2022-92927

J Lit Pharm Sci

2022

DOI: 10.5336/pharmsci.2022-92927

|View full text |Cite

Infusion-Related Reactions with Anti-CD20 Monoclonal Antibody Treatments in Multiple Sclerosis: Traditional Review

Cansu GÖNCÜOĞLU¹,

Kübra Nur ÖKSÜZOĞLU²,

Aygin BAYRAKTAR EKİNCİOĞLU³

Abstract: Multiple sclerosis (MS) is chronic and autoimmune disease that is characterized by central nervous system damage. It is estimated that 2.8 million peo-ple have MS in the world and its incidence was found to be 2.1 per 100,000 people per year in a study involving 75 countries. 1 Although MS is a common dis-

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Patient and Physician Perspectives of Treatment Burden in Multiple Sclerosis

Singer,

Morgan,

Stamm

et al. 2024

Neurol Ther

View full text Add to dashboard Cite

The number of disease-modifying therapies (DMTs) approved for the treatment of multiple sclerosis (MS) has greatly increased in recent decades, leading to higher treatment complexity. DMTs can differ in mode and frequency of administration, benefit–risk profile, and associated costs. Patients with MS contend not only with the burden of their chronic disease but also with the treatment burden of their MS therapy. Adhering to dosing schedules and infusion appointments can be difficult for busy, working-age patients or those with limited access to transportation. Patients and healthcare professionals (HCPs) may have differing priorities, concerns, and preferences when selecting treatment, potentially affecting treatment satisfaction and, importantly, adherence. Additionally, patients face direct and indirect costs related to treatment. These factors can all contribute to a high treatment burden on patients, impacting their quality of life and potentially leading to worse patient outcomes. HCPs, patients, and caregivers must work together to alleviate treatment burden through effective communication, shared decision-making, appreciating each other’s perspectives, and additional HCP support. Consideration of treatment burden into clinical guidelines is also warranted. In this review, we examine key factors impacting treatment burden for patients with MS, with a focus on the patient perspective as provided by our patient authors, and provide strategies to minimize treatment burden.

show abstract

Patient and Physician Perspectives of Treatment Burden in Multiple Sclerosis

Singer,

Morgan,

Stamm

et al. 2024

Neurol Ther

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Infusion-Related Reactions with Anti-CD20 Monoclonal Antibody Treatments in Multiple Sclerosis: Traditional Review

Cited by 1 publication

References 41 publications

Patient and Physician Perspectives of Treatment Burden in Multiple Sclerosis

Patient and Physician Perspectives of Treatment Burden in Multiple Sclerosis

Contact Info

Product

Resources

About